Journal of Clinical Endocrinology & Metabolism, Vol 72, 444-454, Copyright © 1991 by Endocrine Society

ARTICLES

Nocturnal elevation of glucose levels during fasting in noninsulin- dependent diabetes

ET Shapiro, KS Polonsky, G Copinschi, D Bosson, H Tillil, J Blackman, G Lewis and E Van Cauter
Department of Medicine, University of Chicago, Illinois 60637.

To define the spontaneous diurnal variations in glucose regulation during fasting in noninsulin-dependent diabetes (NIDDM), we measured circulating levels of glucose, insulin, C-peptide, GH, cortisol, and glucagon at 15-min intervals in 11 patients with untreated diabetes and 7 matched control subjects studied during a 24-h period. The rates of insulin secretion were derived from the concentrations of C-peptide by deconvolution using a two-compartment mathematical model for C-peptide distribution and metabolism. In both groups of subjects, despite continued fasting, glucose levels stopped declining in the evening and subsequently rose throughout the night to reach a morning maximum. Elevated levels persisted until noon. The morning glucose maximum corresponded to a relative increase of 23.8 +/- 5.5% above the evening nadir in NIDDM patients and 13.2 +/- 4.6% in nondiabetic subjects (P less than 0.05). In NIDDM patients, insulin levels and insulin secretion rates did not parallel the nocturnal glucose changes. In contrast, in control subjects, this nocturnal glucose rise coincided with a similar increase in insulin secretion rates. Cortisol concentrations in patients with NIDDM were higher than those in control subjects throughout the study period (P less than 0.001) and rose earlier in the evening than in control subjects, thus failing to demonstrate the normal nocturnal suppression. In both groups of subjects, the nighttime glucose elevation was temporally and quantitatively correlated with the circadian cortisol rise. GH secretion was increased in the evening and nighttime periods compared to the daytime values, and in NIDDM patients, but not in control subjects, the size of the morning glucose elevation was directly related to the magnitude of this increase in GH secretion (r = 0.88; P less than 0.01). Glucagon concentrations were similar in both groups of subjects and remained essentially constant throughout the study period. We hypothesize that the nocturnal glucose rise that occurs during fasting represents a normal diurnal variation in the set-point of glucose regulation amplified by counterregulatory mechanisms activated by the fasting condition.

This article has been cited by other articles:

				O. Chan, K. Inouye, E. M. Akirav, E. Park, M. C. Riddell, S. G. Matthews, and M. Vranic Hyperglycemia does not increase basal hypothalamo-pituitary-adrenal activity in diabetes but it does impair the HPA response to insulin-induced hypoglycemia Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2005; 289(1): R235 - R246. [Abstract] [Full Text] [PDF]

				O. Chan, K. Inouye, E. Akirav, E. Park, M. C. Riddell, M. Vranic, and S. G. Matthews Insulin Alone Increases Hypothalamo-Pituitary-Adrenal Activity, and Diabetes Lowers Peak Stress Responses Endocrinology, March 1, 2005; 146(3): 1382 - 1390. [Abstract] [Full Text] [PDF]

				O. Chan, S. Chan, K. Inouye, K. Shum, S. G. Matthews, and M. Vranic Diabetes Impairs Hypothalamo-Pituitary-Adrenal (HPA) Responses to Hypoglycemia, and Insulin Treatment Normalizes HPA but not Epinephrine Responses Diabetes, June 1, 2002; 51(6): 1681 - 1689. [Abstract] [Full Text] [PDF]

				A. P. Richardson and J. A. Tayek Type 2 diabetic patients may have a mild form of an injury response: a clinical research center study Am J Physiol Endocrinol Metab, June 1, 2002; 282(6): E1286 - E1290. [Abstract] [Full Text] [PDF]

				O. Chan, K. Inouye, M. Vranic, and S. G. Matthews Hyperactivation of the Hypothalamo-Pituitary-Adrenocortical Axis in Streptozotocin-Diabetes Is Associated with Reduced Stress Responsiveness and Decreased Pituitary and Adrenal Sensitivity Endocrinology, May 1, 2002; 143(5): 1761 - 1768. [Abstract] [Full Text] [PDF]

				O. Chan, S. Chan, K. Inouye, M. Vranic, and S. G. Matthews Molecular Regulation of the Hypothalamo-Pituitary-Adrenal Axis in Streptozotocin-Induced Diabetes: Effects of Insulin Treatment Endocrinology, November 1, 2001; 142(11): 4872 - 4879. [Abstract] [Full Text] [PDF]

				M. Axelsen, P. Lonnroth, R. A. Lenner, M.-R. Taskinen, and U. Smith Suppression of nocturnal fatty acid concentrations by bedtime carbohydrate supplement in type 2 diabetes: effects on insulin sensitivity, lipids, and glycemic control Am. J. Clinical Nutrition, May 1, 2000; 71(5): 1108 - 1114. [Abstract] [Full Text] [PDF]

				E. Van Cauter, K. S. Polonsky, and A. J. Scheen Roles of Circadian Rhythmicity and Sleep in Human Glucose Regulation Endocr. Rev., October 1, 1997; 18(5): 716 - 738. [Abstract] [Full Text]

				C.-M. Hwu, C. F. Kwok, T.-Y. Lai, K.-C. Shih, T.-S. Lee, L.-C. Hsiao, S.-H. Lee, V. S. Fang, and L.-T. Ho Growth Hormone (GH) Replacement Reduces Total Body Fat and Normalizes Insulin Sensitivity in GH-Deficient Adults: A Report of One-Year Clinical Experience J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3285 - 3292. [Abstract] [Full Text] [PDF]